Oregon

Overview

Oregon legalized medical cannabis via Ballot Measure 67 of November 3, 1998 (54.6% approval), creating the Oregon Medical Marijuana Program (OMMP) administered by the Oregon Health Authority. Adult-use cannabis was legalized via Ballot Measure 91 of November 4, 2014 (56.1% approval) (the Control, Regulation, and Taxation of Marijuana Act) codified within Oregon Revised Statutes Chapter 475C. Licensed adult-use retail sales began October 1, 2015.

Adult-use regulation is administered by the Oregon Liquor and Cannabis Commission (OLCC); medical-program oversight remains with the Oregon Health Authority (OHA).

Adult-use (Measure 91, 2014)

• Public possession: 2 ounces of cannabis flower (or equivalent in other forms: 16 ounces solid edibles, 72 ounces liquid edibles, 10 grams concentrate, 1 ounce topicals).
• In-residence: up to 8 ounces at home.
• Home cultivation: up to 4 plants per household, kept out of public view.
• Tax: 17% state cannabis tax + optional local tax up to 3%.
• Past convictions: SB 364 (2015) and subsequent measures created expungement and record-setting pathways for prior cannabis offenses.

Medical program (Measure 67, 1998)

Qualifying conditions

OMMP enumerates a defined list of qualifying conditions:

• Cancer
• Glaucoma
• HIV/AIDS
• Cachexia
• Severe pain
• Severe nausea
• Seizures (including epilepsy)
• Persistent muscle spasms (including multiple sclerosis)
• Alzheimer's disease
• Post-traumatic stress disorder
• Degenerative or pervasive neurological condition

Patient access

• Possession: up to 24 ounces of usable cannabis plus 6 mature plants and 18 immature plants per registered patient.
• Approved forms: flower, edibles, oils, tinctures, capsules, vapes, topicals.
• Home cultivation: registered patients retain the more generous medical cultivation limit of 6 mature plants and 18 immature plants, substantially above the 4-plant adult-use household cap.
• Reciprocity: Oregon does not formally recognize out-of-state medical cards; visiting patients aged 21+ may purchase from any OLCC-licensed retailer.
• Tax: medical sales to registered patients are exempt from the 17% state cannabis tax.

Recreational penalties

Possession of cannabis in excess of adult-use limits is regulated under ORS Chapter 475C and ORS 475.864. Most over-limit possession is treated as a violation or misdemeanor; unlicensed manufacture or distribution scales to felony depending on quantity and circumstance. Use in public is prohibited and subject to civil penalty.

Patients and caregivers

• Patient minimum age: 18. Minor patients require a parent or legal guardian as designated caregiver plus practitioner certification.
• Caregiver minimum age: 18.
• Caregivers per patient: up to 1 designated primary caregiver per patient.
• Caregiver registration: via the OMMP at the Oregon Health Authority; criminal background check.

Historical context

Oregon's 1973 decriminalization of cannabis possession was the first such action by any US state, predating both Oregon's 1998 medical-cannabis program and its 2014 adult-use legalization by decades. Oregon was also among the first states to operate a regulated medical cultivation framework, and Measure 91 in 2014 placed Oregon among the second wave of adult-use states alongside Alaska and the District of Columbia, after the 2012 Colorado and Washington measures.

Patient registration steps

1. Schedule a visit with an Oregon-licensed physician, nurse practitioner, or physician assistant willing to certify a qualifying condition. The certifying provider must establish a bona fide provider-patient relationship.
2. The provider submits a written certification through the Oregon Health Authority OMMP portal.
3. The patient applies through the OMMP portal, submits identity documents, proof of Oregon residency, and a current photo. The standard application fee is $200; reduced to $60 for veterans, Oregon Health Plan recipients, SNAP recipients, and SSI/SSDI recipients.
4. Approved patients receive an OMMP card valid for one year and renewable. The card authorizes purchases at any OLCC-licensed retailer with the medical-tax exemption and authorizes the expanded patient cultivation rights.

Minor patients require a parent or legal guardian as designated caregiver and a second physician's concurring certification. Caregivers complete a separate application and Oregon State Police background check.

Reciprocity and visiting patients

Oregon's framework is dual-track for visitors:

• Adult-use: any visitor 21 or older with a government-issued photo ID may purchase from an OLCC-licensed retailer under the 2 oz / 10 g caps.
• Medical: Oregon does not formally recognize out-of-state medical cards. Visiting medical patients access cannabis through the adult-use retail framework.

The medical-program tax exemption (no 17% state cannabis tax) is significant for high-volume patients. Visiting medical patients cannot access this exemption or the higher 24 oz medical possession cap.

Employment and workplace

Oregon is an at-will employment state. The Bureau of Labor and Industries and the Oregon Supreme Court (in litigation) have generally upheld broad employer discretion to discipline employees for cannabis use:

• Safety-sensitive positions: employers may continue to enforce drug-free workplace policies for safety-sensitive roles.
• Federal contractor and DOT-regulated positions: federal drug-free workplace and DOT testing rules supersede state-level protection.
• No statutory off-duty use protection: Oregon law does not create a broad "lawful off-duty activity" defense for cannabis use. The Oregon Supreme Court's decision in Emerald Steel Fabricators, Inc. v. Bureau of Labor and Industries (2010) held that federal CSA preemption permits Oregon employers to discipline registered medical patients for off-duty cannabis use.
• Workers' compensation: post-incident testing positive for THC may affect benefits.
• Pre-employment testing: Oregon law does not prohibit pre-employment cannabis testing or adverse hiring action based on positive results.

Public-employee positions, healthcare licensing, and CDL holders face additional licensing-board exposure beyond employer discipline. The 2021 SB 471 expanded protections for some categories of workers but did not displace the Emerald Steel framework broadly.

Hemp-derived intoxicants

Oregon placed hemp-derived intoxicating cannabinoids under OLCC regulatory authority through 2021 and 2023 legislation. Delta-8 THC, delta-9 THC from hemp, delta-10 THC, THC-O, HHC, and similar compounds are restricted to retail channels licensed under the cannabis framework. Hemp-derived products exceeding defined THC thresholds are not lawful for retail sale outside the licensed cannabis supply chain.

Market history

Oregon's adult-use market was among the most rapidly oversupplied in the US. Aggressive cultivator licensing in 2016-2018 produced substantial wholesale price compression (Oregon flower wholesale prices reached among the lowest in any legal-cannabis state by 2019). Subsequent license caps, micro-cultivator framework adjustments, and operator consolidation have stabilized the market but Oregon remains a low-price reference point in US cannabis economics.

Interstate-export legislation (SB 582 of 2019) authorized Oregon cannabis exports to other legal states upon federal authorization. The April 2026 federal Schedule III rescheduling order has renewed discussion of interstate compacts, but federal law continues to prohibit interstate cannabis commerce regardless of state authorization.

Recent legislative history

Notable developments:

• 1973: Oregon decriminalized cannabis possession (first US state).
• 1998: Measure 67 (OMMP medical cannabis) approved.
• 2014: Measure 91 (adult-use legalization) approved.
• 2015: licensed adult-use retail sales began October 1.
• 2019: SB 582 (interstate-export framework, contingent on federal authorization).
• 2020-2024: market stabilization, license cap adjustments, hemp-derived intoxicant regulation, social-equity license categories.
• 2025-2026: continued legislative work on micro-cultivator licensing, on-premises consumption pilots, and interstate-compact preparation.

The April 2026 federal Schedule III rescheduling order produced significant Oregon regulatory engagement on interstate-commerce preparation. OLCC issued guidance noting that interstate cannabis commerce remains prohibited pending further federal action.

Tribal jurisdiction

Oregon includes nine federally recognized tribal nations. The Confederated Tribes of the Grand Ronde, Confederated Tribes of Warm Springs, Coquille Indian Tribe, Klamath Tribes, and other tribes have engaged in tribal cannabis governance or operations. Tribal jurisdiction is distinct from state jurisdiction; cannabis transported off tribal land onto state or federal land is subject to applicable non-tribal law.

Federal context

Federal jurisdiction layers additional exposure on federal land, federal courthouses, military installations (Camp Withycombe, Oregon Air National Guard installations, various Coast Guard installations), and interstate highways. Crater Lake National Park, Oregon Caves National Monument, John Day Fossil Beds National Monument, Newberry National Volcanic Monument, and substantial Bureau of Land Management and US Forest Service land (including the Pacific Crest Trail corridor) fall under federal jurisdiction where cannabis prohibition applies. I-5, I-84, I-205, and US-26 corridors see federal drug-interdiction activity. The California-Oregon border sees substantial enforcement attention given the long history of cross-border cannabis traffic.